If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Block Admission

26 Sep 2023 15:23

RNS Number : 7242N
Marlowe PLC
26 September 2023
 

26 September 2023

 

Marlowe plc

 

Block Admission

 

Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services and software which assure regulatory compliance, announces that application has been made for a block admission of 699,000 ordinary shares in the capital of the Group ("Ordinary Shares") to be admitted to trading on AIM ("Admission") in respect of new Ordinary Shares which may be issued from time to time on the exercise of options awarded under Marlowe's 2020 SAYE scheme (the "SAYE Options"). The award of the SAYE Options was announced by Marlowe on 2 September 2020.

New Ordinary Shares issued under the block admission will rank pari passu in all respects with Ordinary Shares and it is expected that Admission will become effective at 8.00 a.m. on 2 October 2023.

There is no change to the Group's issued share capital as a result of this block admission and, following Admission the Group will continue to have 96,481,891 Ordinary Shares in issue. There are no shares held in treasury and thus the total number of voting rights in the Group is 96,481,891.

The Group will notify on a monthly basis when there are changes to the issued share capital of the Group, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Group, under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Marlowe plc

Alex Dacre, Chief Executive

www.marloweplc.com

Adam Councell, Chief Financial Officer

Tel: +44 (0) 203 813 8498

Benjamin Tucker, Investor Relations Manager

Cavendish Securities plc (Nominated Adviser and Joint Broker)

Ben Jeynes

Tel: +44 (0)20 7220 0500

George Lawson

Berenberg (Joint Broker)

Ben Wright

Tel: +44 (0)20 3207 7800

Mark Whitmore

Stifel (Joint Broker)

Matthew Blawat

Tel: +44 (0)20 7710 7688

Francis North

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

About Marlowe plc

Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSMZGZLDVLGFZM
Date   Source Headline
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:51 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20247:00 amRNSPublication of Notice of AGM and Annual Report
9th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:00 amRNSTransaction in Own Shares
25th Jul 20248:18 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSTransaction in Own Shares
22nd Jul 20242:52 pmRNSHolding(s) in Company
22nd Jul 202412:51 pmRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTransaction in Own Shares
19th Jul 202410:36 amRNSNotice of Full Year Results
19th Jul 202410:36 amRNSTransaction in Own Shares
18th Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20242:55 pmRNSHolding(s) in Company
17th Jul 20247:01 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20243:04 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSTransaction in Own Shares
10th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20245:31 pmRNSTransaction in Own Shares
5th Jul 20245:46 pmRNSTransaction in Own Shares
13th Jun 20243:38 pmRNSHolding(s) in Company
3rd Jun 20247:00 amRNSDivestment, Special Dividend & Board Changes
23rd May 20245:27 pmRNSDirector/PDMR Shareholding & Holding(s) in Company
23rd May 20242:49 pmRNSExercise of Share Options & Total Voting Rights
22nd May 20247:00 amRNSTrading Update
14th May 20247:00 amRNSChange of Advisers
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20242:54 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20244:45 pmRNSBlock listing Interim Review
18th Mar 20247:00 amRNSBoard Changes; Update re: Returns of Capital
26th Feb 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
22nd Feb 20247:00 amRNSDisposal and Directorate Change
15th Jan 202410:23 amRNSChange of Nominated Adviser and Joint Broker
30th Nov 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for the six months to 30 Sept 2023
23rd Nov 20237:00 amRNSNotice of Interim Results
31st Oct 20234:30 pmRNSTotal Voting Rights
27th Sep 20235:18 pmRNSHolding(s) in Company
26th Sep 20233:23 pmRNSBlock Admission
13th Sep 20236:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.